Regulation & law · 20/11/2024Updated: 10/16/2026 · 1 min read
National Institute of Allergy and Infectious Diseases to Grant Exclusive License to Columbia University
Summary
The National Institute of Allergy and Infectious Diseases is considering granting an exclusive, sublicensable patent license to Columbia University to practice inventions related to Ebola virus detection and differentiation.
Original source language: Federal Register — All DocumentsOpen original release →